Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission

Go back to Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission
Meridian Bioscience, Inc. (NASDAQ: VIVO) Delayed: 4.25 -0.11 (2.52%)
Previous Close $4.36    52 Week High $21.49 
Open $4.35    52 Week Low $15.75 
Day High $4.42    P/E 4.83 
Day Low $4.11    EPS $0.88 
Volume 252,335